Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:21 pm Sale | 13G | Aravive Inc. ARAV | BAKER BROS. ADVISORS LP | 3,863,568 4.990% | -722,836 (-15.76%) | View |
| 2024-02-14 10:24 am Purchase | 13G | Aravive Inc. ARAV | BIOTECHNOLOGY VALUE FUND L P | 8,164,510 9.990% | 2,055,452 (+33.65%) | View |
| 2024-02-09 5:14 pm Sale | 13G | Aravive Inc. ARAV | Artal International S.C.A. | 7,609,522 9.400% | -4,572,515 (-37.53%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | Aravive Inc. ARAV | BAKER BROS. ADVISORS LP | 4,586,404 7.500% | 4,586,404 (New Position) | View |
| 2023-02-10 7:28 pm Purchase | 13G | Aravive Inc. ARAV | Artal International S.C.A. | 12,182,037 9.900% | 10,870,746 (+829.01%) | View |
| 2022-12-28 4:00 pm Purchase | 13D | Aravive Inc. ARAV | Zhang Eric | 2,029,634 3.400% | 1,169,868 (+136.07%) | View |
| 2022-12-27 4:05 pm Purchase | 13D | Aravive Inc. ARAV | Giaccia Amato | 1,725,244 2.900% | 546,932 (+46.42%) | View |
| 2022-11-07 4:50 pm Purchase | 13G | Aravive Inc. ARAV | BIOTECHNOLOGY VALUE FUND L P | 6,109,058 9.990% | 6,109,058 (New Position) | View |
| 2022-11-03 4:45 pm Purchase | 13D | Aravive Inc. ARAV | Eshelman Ventures LLC | 26,451,103 43.600% | 26,451,103 (New Position) | View |
| 2022-04-05 4:15 pm Purchase | 13D | Aravive Inc. ARAV | ESHELMAN FREDRIC N | 10,111,882 34.000% | 5,806,201 (+134.85%) | View |
| 2022-02-11 4:48 pm Unchanged | 13G | Aravive Inc. ARAV | New Leaf Biopharma Opportunities II L.P. | 946,423 4.500% | 0 (Unchanged) | View |
| 2022-01-05 6:32 pm Purchase | 13D | Aravive Inc. ARAV | ESHELMAN FREDRIC N | 4,305,681 19.990% | 472,828 (+12.34%) | View |
| 2021-04-15 07:00 am Sale | 13D | Aravive Inc. ARAV | Tabibiazar Raymond | 1,606,511 7.900% | -29,074 (-1.78%) | View |
| 2021-03-23 07:05 am Purchase | 13D | Aravive Inc. ARAV | Giaccia Amato | 1,178,312 5.900% | 15,704 (+1.35%) | View |
| 2021-02-18 7:55 pm Sale | 13D | Aravive Inc. ARAV | Liu Qianye | 449,910 2.800% | -409,856 (-47.67%) | View |
| 2021-02-18 7:00 pm Purchase | 13D | Aravive Inc. ARAV | ESHELMAN FREDRIC N | 3,832,853 19.800% | 2,901,755 (+311.65%) | View |
| 2021-02-12 8:45 pm Sale | 13G | Aravive Inc. ARAV | Artal International S.C.A. | 1,311,291 8.200% | -38,709 (-2.87%) | View |
| 2020-04-15 7:56 pm Purchase | 13D | Aravive Inc. ARAV | ESHELMAN FREDRIC N | 931,098 5.800% | 931,098 (New Position) | View |
| 2020-02-12 5:36 pm Sale | 13G | Aravive Inc. ARAV | New Leaf Biopharma Opportunities II L.P. | 946,423 6.300% | -24,236 (-2.50%) | View |
| 2019-12-10 4:16 pm Purchase | 13G | Aravive Inc. ARAV | Artal International S.C.A. | 1,350,000 9.000% | 1,350,000 (New Position) | View |